基于PI3K/Akt信号通路的中医药改善胰岛素抵抗的研究进展
方玲1 张琪2 魏恩韬1 贾紫珮1
1.陕西中医药大学基础医学院,陕西咸阳 712046;
2.陕西中医药大学医学科研实验中心,陕西咸阳 712046
Research progress on improvement of insulin resistance based on PI3K /Akt signal pathway in traditional Chinese medicine
FANG Ling1 ZHANG Qi2 WEI Entao1 JIA Zipei1
1.Basic Medical College, Shaanxi University of Chinese Medicine, Shaanxi Province, Xianyang 712046, China;
2.Medical Research Experiment Center, Shaanxi University of Chinese Medicine, Shaanxi Province, Xianyang 712046, China
摘要 胰岛素生理作用的发挥与其信号转导的正常运行密切相关,转导途径的任何一个环节受损均可导致胰岛素抵抗(IR),PI3K/Akt是胰岛素信号传导的经典途径,也是中医药预防治疗IR相关疾病的重要靶点之一。本文概述了PI3K/Akt信号通路及其与IR的关系,并以此为出发点,将近年来应用于实验研究的中药单体及复方进行简要综述,以期为研究者更深入地探讨中医药防治IR的机制提供参考。
关键词 :
PI3K/Akt信号通路 ,
胰岛素抵抗 ,
中医药 ,
研究进展
Abstract :The physiological function of insulin is closely related to the normal operation of insulin signal transduction. Impaired in any part of the transduction pathway can lead to insulin resistance(IR). PI3K/Akt signaling is the classical pathway of insulin signaling, and it is also one of the important targets for the prevention and treatment of IR-related diseases in Chinese medicine. This article summarizes the PI3K/Akt signal pathway and its relationship with IR, and as a starting point, a brief review of traditional Chinese medicine monomers and compounds used in experimental research in recent years, in order to provide researchers with more in-depth study of Chinese medicine prevention and treatment of IR.
Key words :
PI3K/Akt signaling pathway
Insulin resistance
Traditional Chinese medicine
Research progress
基金资助: 国家自然科学基金资助项目(81470543、81774295)。
通讯作者:
张琪(1977.2-),男,博士,硕士生导师,教授;研究方向:心血管疾病的中西医结合防治。
作者简介 : 方玲(1992.3-),女,陕西中医药大学基础医学院2016级中西医结合基础专业在读硕士研究生;研究方向:心血管疾病的中西医结合防治。
[1] Ruderman NB,Carling D,Prentki M,et al. AMPK,insulin resistance,and the metabolic syndrome [J]. J Clin Invest,2013,123(7):2764-2772.
[2] 林玉芳,韩薇,李寅,等.中医药对胰岛素抵抗相关信号通路影响的研究进展[J].上海中医药大学学报,2015,29(5):98-101.
[3] Hawkins PT,Stephens LR. PI3K signalling in inflammation [J]. Biochim Biophys Acta,2015,1851(6):882-897.
[4] Okkenhaug K. Signaling by the phosphoinositide 3-kinase family in immune cells [J]. Annu Rev Immunol,2013,31(5):675-704.
[5] Jean S,Kiger AA. Classes of phosphoinositide 3-kinases at a glance [J]. J Cell Sci,2014,127(5):923-928.
[6] Osorio-Fuentealba C,Klip A. Dissecting signalling by individual Akt/PKB isoforms,three steps at once [J]. Biochem J,2015,470(2):13-16.
[7] Dummler B,Hemmings BA. Physiological roles of PKB/Akt isoforms in development and disease [J]. Biochem Soc Trans,2007,35(2):231-235.
[8] Schultze SM,Jensen J,Hemmings BA,et al. Promiscuous affairs of PKB/AKT isoforms in metabolism [J]. Arch Physiol Biochem,2011,117(2):70-77.
[9] Kadowaki T,Ueki K,Yamauchi T,et al. Snapshot:insulin signaling pathways [J]. Cell,2012,148(3):624.
[10] Hennessy BT,Smith DL,Ram PT,et al. Exploiting the PI3K/AKT pathway for cancer drug discovery [J]. Nat Rev Drug Discov,2005,4(12):988-1004.
[11] Guo S. Insulin signaling,resistance,and the metabolic syn-drome:insights from mouse models into disease mechanisms [J]. J Endocrinol,2014,220(2):1-23.
[12] Liu Q,Li X,Li C,et al. 1-Deoxynojirimycin alleviates insulin resistance via activation of insulin signaling PI3K/AKT pathway in skeletal muscle of db/db mice [J]. Molecules,2015,20(12):21 700-21 714.
[13] Zhang Y,Huang NQ,Yan F,et al. Diabetes mellitus and Alzheimer′s disease:GSK-3β as a potential link [J]. Behav Brain Res,2017,339:57-65.
[14] 王秀秀,李威,刘逸超,等.小檗碱对胰岛素抵抗卵巢甾体激素体外合成和代谢的调控作用[J].中国中西医结合杂志,2010,30(2):161-166.
[15] 李慕白,刘畅,匡洪影,等.小檗碱对多囊卵巢综合征患者子宫内膜胰岛素信号分子的调节作用[J].中医药学报,2016,44(2):30-32.
[16] 龚又明,郑显辉,谢鸣坤,等.小檗碱对HepG2胰岛素抵抗细胞PI3K/AKT1/GLUT1信号通路的调控作用[J].新中医,2017,49(8):1-4.
[17] 黄桂红,刘天旭,朱钊铭,等.鬼针草黄酮对HepG2胰岛素抵抗细胞PI3K/AKT1/GLUT4 信号通路的调控作用[J].实用医学杂志,2016,32(24):3994-3998.
[18] 王超,张会欣,邢邯英,等.氧化苦参碱改善高脂诱导ApoE-/-小鼠的胰岛素抵抗 [J].中国病理生理杂志,2016, 32(11):2010-2014.
[19] 张茁,孙文,刘铜华,等.山柰酚对2型糖尿病小鼠骨骼肌PI3K-AKT-GLUT4信号通路的影响[J].世界科学技术-中医药现代化,2016,18(7):1139-1143.
[20] 尚文斌,郭超,赵娟,等.人参皂苷Rb1通过上调脂肪组织葡萄糖转运体促进葡萄糖消耗[J].中国中药杂志,2014,39(22):4448-4452.
[21] Chen WJ,Wang JL,Luo Y,et al. Ginsenoside Rb1 and compound K improve insulin signaling and inhibit ER stress-associated NLRP3 inflammasome activation in adipose tissue [J]. J Ginseng Res,2016,40(4):351-358.
[22] Feng HL,Dang HZ,Fan H,et al. Curcumin ameliorates insulin signalling pathway in brain of Alzheimer′s disease transgenic mice [J]. Int J Immunopathol Pharmacol,2016,29(4):734-741.
[23] Zheng XK,Ke YY,Feng AZ,et al. The mechanism by which amentoflavone improves insulin resistance in HepG2 cells [J]. Molecules,2016,21(5):624.
[24] Nie XQ,Chen HH,Zhang JY,et al. Rutaecarpine ameliorates hyperlipidemia and hyperglycemia in fat-fed,streptozotocin-treated rats via regulating the IRS-1/PI3K/Akt and AMPK/ACC2 signaling pathways [J]. Acta Pharmacologica Sin,2016,37(4):483-496.
[25] 刘颖,邢福祺,张丽华,等.丹栀逍遥散调控多囊卵巢综合征大鼠胰岛素抵抗的作用机制[J].实用医学杂志,2012,28(17):2842-2844.
[26] 王晓敏,罗颖,高增光.丹栀逍遥散对糖尿病抑郁大鼠肝组织IRS-2—PI3-K信号通路的作用[J].中华中医药学刊,2013,31(11):2450-2452.
[27] 戴冰,吴沁璇,肖子曾,等.六味地黄汤及其水提醇溶部位对2型糖尿病模型大鼠脂肪组织中PI3K/Akt信号通路的影响[J].中成药,2016,38(2):428-430.
[28] 许金榜,王小云,纪峰,等.痰脂消颗粒联合二甲双胍治疗肥胖型多囊卵巢综合征伴胰岛素抵抗的临床观察[J].中华中医药学刊,2017,35(6):1431-1434.
[29] 许金榜,王小云,纪峰,等.痰脂消汤调控PCOS-IR模型大鼠卵巢PI3K/Akt途径探讨[J].中国实验方剂学杂志,2016,22(24):156-160.
[30] 张先慧,胡照娟,张艳红,等.辛开苦降方对初发2型糖尿病KKay小鼠肝脏胰岛素抵抗及IRS-2/PI3K通路的影响[J].中华中医药杂志,2015,30(5):1774-1779.
[31] 洪艳丽,吴飞.补肾化痰方对多囊卵巢综合征胰岛素抵抗Akt通路调控的实验研究[J].中国中西医结合杂志,2014,34(2):230-234.
[32] Yu N,Fang X,Zhao D,et al. Anti-Diabetic effects of Jiang Tang Xiao Ke Granule via PI3K/Akt signalling pathway in type 2 diabetes KKay mice [J]. PLoS One,2017,12(1):e0 168 980.
[33] Mo FF,An T,Zhang ZJ,et al. Jiang Tang Xiao Ke Granule play an anti-diabetic role in diabetic mice pancreatic tissue by regulating the mRNAs and microRNAs associated with PI3K-Akt signaling pathway [J]. Front Pharmacol,2017,8(6):795.
[34] Cao H,Tuo L,Tuo Y,et al. Immune and metabolic regulation mechanism of Dangguiliuhuang Decoction against insulin resistance and hepatic steatosis [J]. Front Pharmacol,2017,8:445.
[1]
杨思秋 侯胜田. 北京市老年人对中医药健康养老服务的态度调查分析 [J]. 中国医药导报, 2018, 15(8): 35-39.
[2]
苏晓琳1 王江威1 赵婉1 杨炳友1 匡海学1 王秋红1,2. 独活寄生汤治疗膝骨性关节炎作用机制的现代药理学研究进展 [J]. 中国医药导报, 2018, 15(7): 36-39.
[3]
罗远国 覃万安 吴家昌 林舟丹 杨华. 复合组织瓣修复静脉功能障碍患者组织缺损的研究进展 [J]. 中国医药导报, 2018, 15(7): 44-46,59.
[4]
杨其霖1 田思胜1 马梅青2. 中医药古籍文献数据库建设研究与思考 [J]. 中国医药导报, 2018, 15(7): 119-122.
[5]
王丽 王苹 沈俊辉. 基于Hadoop的中医药大数据平台基础架构的设计与研究 [J]. 中国医药导报, 2018, 15(6): 158-162.
[6]
杨弘光 施建蓉 宋欣阳 李海英 王硕. 论势在必行的中医药供给侧改革 [J]. 中国医药导报, 2018, 15(4): 90-93,107.
[7]
崔圆月 胡凌娟 孟浩婷. “一带一路”倡议下的中医药服务贸易 [J]. 中国医药导报, 2018, 15(4): 108-112.
[8]
祝超瑜 肖元元 叶阳 刘梦丹 曾媛媛 魏丽▲ . 非诺贝特对胰岛素抵抗大鼠脂肪甘油三酯脂酶表达的影响 [J]. 中国医药导报, 2018, 15(4): 4-7,17.
[9]
李晗 王良滨. 基于Web of Science近十年我国5所中医药大学科技论文文献计量学研究 [J]. 中国医药导报, 2018, 15(21): 35-39.
[10]
付丹. 25-羟基维生素D与妊娠期糖尿病孕妇胰岛素抵抗的关系及意义 [J]. 中国医药导报, 2018, 15(20): 79-82.
[11]
刘冰1 霍会永1 冯社军1 曹凌1 赵现1 曹妍1 王如科2 李军涛1. Tizanidine对胶质瘤细胞U251增殖、迁移及凋亡的影响 [J]. 中国医药导报, 2018, 15(2): 27-31.
[12]
张豪1 田苗2 孙小虎3 欧阳露4. 调控Nedd4-2泛素化降解上皮离子通道的研究进展 [J]. 中国医药导报, 2018, 15(19): 37-41.
[13]
杜启亘 米香琴 徐宏伟 商玮珉 周立平 陈巍▲. 心肌运动定量技术在多囊卵巢合并胰岛素抵抗患者左室纵向心肌功能评价中的价值 [J]. 中国医药导报, 2018, 15(19): 71-74,86.
[14]
陈畏兵 马红梅▲ 沈向英. 长期鼻饲老年患者预防误吸的研究进展 [J]. 中国医药导报, 2018, 15(18): 20-23,39.
[15]
李靖华1 姚子昂2 钟丰鹰1 翟兴3 王苹3. 中医学内涵视角下对《饮膳正要》的研究回顾与再思考 [J]. 中国医药导报, 2018, 15(18): 124-126.